Clinical trialObsCompleted
Study of Changes and Characteristics of Genes in Patients With Pancreatic Cancer for Better Treatment Selection
Comprehensive Molecular Characterization of Advanced Pancreatic Ductal Adenocarcinomas (PDAC) for Better Treatment Selection: A Prospective Study
- Outcome
- Finished, no results posted
- Phase
- Obs
- Status
- Completed
- Study type
- Observational
- Start
- December 2015
- Expected end
- August 2025
- Enrollment
- 332 participants
- Sites
- 4
- Primary outcomes
- The feasibility of prospectively identifying subgroups of patients with advanced PDAC who have distinct genomic characteristics for better treatment selection while undergoing 1st-line chemotherapy using next generation sequencing.
- Sponsor
- Other
- Results posted
- No
- Last update
- 18 November 2025
These are registry fields. A trial card, with population, design, endpoints and result direction each tied to a quote, is not in the data yet.
Ask this document
Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess. Only its metadata is loaded so far, so most questions will be declined.
Try
Papers 2
- Builds on itAltered Gene Expression along the Glycolysis-Cholesterol Synthesis Axis Is Associated with Outcome in Pancreatic Cancer. DOI 10.1158/1078-0432.ccr-19-1543↗
- Builds on itGenomics-Driven Precision Medicine for Advanced Pancreatic Cancer: Early Results from the COMPASS Trial. DOI 10.1158/1078-0432.ccr-17-2994↗